[Histonet] Rabbit anti-Galanin (human)

2014-03-26 Thread Leila Etemadi
Hi,

I wonder if any one out there working with Peninsula Rabbit anti-Galanin 
(human)?, I am planing to use it on the rat nervous system tissue which is new 
work for my lab. I will be appreciate if you can share your great protocol with 
me :-)

Cheers,
Leila












___
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet


[Histonet] RE: IHC antibody optimizing validating

2014-03-26 Thread Cartun, Richard
I have not read the entire document yet.  What do they say about using tissues 
that have been fixed and processed elsewhere?

Richard

Richard W. Cartun, MS, PhD
Director, Histology  Immunopathology
Director, Biospecimen Collection Programs
Assistant Director, Anatomic Pathology
Hartford Hospital
80 Seymour Street
Hartford, CT  06102
(860) 972-1596 Office
(860) 545-2204 Fax
richard.car...@hhchealth.org

-Original Message-
From: histonet-boun...@lists.utsouthwestern.edu 
[mailto:histonet-boun...@lists.utsouthwestern.edu] On Behalf Of Terri Braud
Sent: Tuesday, March 25, 2014 3:35 PM
To: histonet@lists.utsouthwestern.edu
Subject: [Histonet] RE: IHC antibody optimizing  validating

CAP is very clear that in order to validate a new antibody, that: once the 
stain has been optimized, that for a well characterized antibody with a limited 
spectrum of antigenic targets, like Chromogranin or PSA, the validation can be 
limited.  A panel of 10 positive and 10 negative neoplasms would be sufficient 
in this setting.  For an antibody that is not well characterized and/or has a 
wide range of reported reactivity, a more extensive validation is necessary.  
The number of tissues tested should in the circumstance be large enough to 
determine whether the staining profile matches that previously described.  An 
exception to the above requirements is that studies nay not be feasible for 
antigens such as ALK that are only seen in rare tumors.
Thus sayeth CAP.
And if you're like me, I am not digging through all my cases to try to come up 
with 30-40 neoplasms for each antibody, so I just order Tissue Micro Arrays 
with the neoplasms I need.  20 positive and 20 negative neoplastic tissues on 
one slide for easy staining and validation.  The money you save on reagents to 
stain one little slide, more than makes up for the cost of the slide.
I hope this helps.

Terri L. Braud, HT(ASCP)
Anatomic Pathology Supervisor
Holy Redeemer Hospital Laboratory
1648 Huntingdon Pike
Meadowbrook, PA 19046
Ph: 215-938-3676
Fax: 215-938-3874

Today's Topics:
   8. IHC antibody optimizing  validating (Davis, Cassie)

Message: 8
Date: Tue, 25 Mar 2014 09:51:07 -0400
From: Davis, Cassie cda...@che-east.org
Subject: [Histonet] IHC antibody optimizing  validating

Will you help me? I understand we are to use the known positives controls that 
the manufactures' recommends in the package insert when optimizing the stains, 
but I need to know what is your general procedure for optimizing (how many 
different staining protocols do you test) and validating a new antibody (how 
many different or known positive and negative tissues do you test [predictive 
markers I understand are 20])?

Cassandra Davis
cda...@che-east.org
302-575-8095

*
-



CONFIDENTIALITY NOTICE:

This E-Mail is intended only for the use of the individual or entity to which 
it was sent. It may contain information that is privileged and/or confidential, 
and the use or disclosure of such information may also be restricted under 
applicable federal and state law. If you received this communication in error, 
please do not distribute any part of it or retain any copies, and delete the 
original E-Mail.
Please notify the sender of any error by E-Mail.

Thank you for your cooperation.


___
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet

This e-mail message, including any attachments, is for the sole use of the 
intended recipient(s) and may contain confidential and privileged information. 
Any unauthorized review, use, disclosure, or distribution is prohibited. If you 
are not the intended recipient, or an employee or agent responsible for 
delivering the message to the intended recipient, please contact the sender by 
reply e-mail and destroy all copies of the original message, including any 
attachments.

___
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet


[Histonet] RE: IHC antibody optimizing validating

2014-03-26 Thread Terri Braud
Fortunately, they say nothing at all because if that were the case, they
would no longer be able to peddle their Proficiency Programs for IHC,
since those too, are fixed and processed elsewhere.

Terri L. Braud, HT(ASCP)
Anatomic Pathology Supervisor
Holy Redeemer Hospital Laboratory
1648 Huntingdon Pike
Meadowbrook, PA 19046
Ph: 215-938-3676
Fax: 215-938-3874


-Original Message-
From: Cartun, Richard [mailto:richard.car...@hhchealth.org]
Sent: Wednesday, March 26, 2014 11:47 AM
To: Terri Braud; histonet@lists.utsouthwestern.edu
Subject: RE: IHC antibody optimizing  validating

I have not read the entire document yet.  What do they say about using
tissues that have been fixed and processed elsewhere?

Richard

Richard W. Cartun, MS, PhD
Director, Histology  Immunopathology
Director, Biospecimen Collection Programs Assistant Director, Anatomic
Pathology Hartford Hospital
80 Seymour Street
Hartford, CT  06102
(860) 972-1596 Office
(860) 545-2204 Fax
richard.car...@hhchealth.org

-Original Message-
From: histonet-boun...@lists.utsouthwestern.edu
[mailto:histonet-boun...@lists.utsouthwestern.edu] On Behalf Of Terri
Braud
Sent: Tuesday, March 25, 2014 3:35 PM
To: histonet@lists.utsouthwestern.edu
Subject: [Histonet] RE: IHC antibody optimizing  validating

CAP is very clear that in order to validate a new antibody, that: once
the stain has been optimized, that for a well characterized antibody
with a limited spectrum of antigenic targets, like Chromogranin or PSA,
the validation can be limited.  A panel of 10 positive and 10 negative
neoplasms would be sufficient in this setting.  For an antibody that is
not well characterized and/or has a wide range of reported reactivity, a
more extensive validation is necessary.  The number of tissues tested
should in the circumstance be large enough to determine whether the
staining profile matches that previously described.  An exception to the
above requirements is that studies nay not be feasible for antigens such
as ALK that are only seen in rare tumors.
Thus sayeth CAP.
And if you're like me, I am not digging through all my cases to try to
come up with 30-40 neoplasms for each antibody, so I just order Tissue
Micro Arrays with the neoplasms I need.  20 positive and 20 negative
neoplastic tissues on one slide for easy staining and validation.  The
money you save on reagents to stain one little slide, more than makes up
for the cost of the slide.
I hope this helps.

Terri L. Braud, HT(ASCP)
-



CONFIDENTIALITY NOTICE:

This E-Mail is intended only for the use of the individual or entity to which
it was sent. It may contain information that is privileged and/or confidential,
and the use or disclosure of such information may also be restricted under 
applicable
federal and state law. If you received this communication in error, please do 
not
distribute any part of it or retain any copies, and delete the original E-Mail.
Please notify the sender of any error by E-Mail.

Thank you for your cooperation.


___
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet


RE: [Histonet] RE: IHC antibody optimizing validating

2014-03-26 Thread joelle weaver
only 1/2 way through reading the article, but Terri makes a good point about 
the proficiency testing.  




Joelle Weaver MAOM, HTL (ASCP) QIHC
 
 Date: Wed, 26 Mar 2014 12:48:46 -0400
 From: tbr...@holyredeemer.com
 To: richard.car...@hhchealth.org; histonet@lists.utsouthwestern.edu
 CC: 
 Subject: [Histonet] RE: IHC antibody optimizing  validating 
 
 Fortunately, they say nothing at all because if that were the case, they
 would no longer be able to peddle their Proficiency Programs for IHC,
 since those too, are fixed and processed elsewhere.  
 
 Terri L. Braud, HT(ASCP)
 Anatomic Pathology Supervisor
 Holy Redeemer Hospital Laboratory
 1648 Huntingdon Pike
 Meadowbrook, PA 19046
 Ph: 215-938-3676
 Fax: 215-938-3874
 
 
 -Original Message-
 From: Cartun, Richard [mailto:richard.car...@hhchealth.org] 
 Sent: Wednesday, March 26, 2014 11:47 AM
 To: Terri Braud; histonet@lists.utsouthwestern.edu
 Subject: RE: IHC antibody optimizing  validating 
 
 I have not read the entire document yet.  What do they say about using
 tissues that have been fixed and processed elsewhere?
 
 Richard
 
 Richard W. Cartun, MS, PhD
 Director, Histology  Immunopathology
 Director, Biospecimen Collection Programs Assistant Director, Anatomic
 Pathology Hartford Hospital
 80 Seymour Street
 Hartford, CT  06102
 (860) 972-1596 Office
 (860) 545-2204 Fax
 richard.car...@hhchealth.org
 
 -Original Message-
 From: histonet-boun...@lists.utsouthwestern.edu
 [mailto:histonet-boun...@lists.utsouthwestern.edu] On Behalf Of Terri
 Braud
 Sent: Tuesday, March 25, 2014 3:35 PM
 To: histonet@lists.utsouthwestern.edu
 Subject: [Histonet] RE: IHC antibody optimizing  validating
 
 CAP is very clear that in order to validate a new antibody, that: once
 the stain has been optimized, that for a well characterized antibody
 with a limited spectrum of antigenic targets, like Chromogranin or PSA,
 the validation can be limited.  A panel of 10 positive and 10 negative
 neoplasms would be sufficient in this setting.  For an antibody that is
 not well characterized and/or has a wide range of reported reactivity, a
 more extensive validation is necessary.  The number of tissues tested
 should in the circumstance be large enough to determine whether the
 staining profile matches that previously described.  An exception to the
 above requirements is that studies nay not be feasible for antigens such
 as ALK that are only seen in rare tumors.
 Thus sayeth CAP.
 And if you're like me, I am not digging through all my cases to try to
 come up with 30-40 neoplasms for each antibody, so I just order Tissue
 Micro Arrays with the neoplasms I need.  20 positive and 20 negative
 neoplastic tissues on one slide for easy staining and validation.  The
 money you save on reagents to stain one little slide, more than makes up
 for the cost of the slide.
 I hope this helps.
 
 Terri L. Braud, HT(ASCP)
 -
 
 
 
 CONFIDENTIALITY NOTICE:
 
 This E-Mail is intended only for the use of the individual or entity to which
 it was sent. It may contain information that is privileged and/or 
 confidential,
 and the use or disclosure of such information may also be restricted under 
 applicable
 federal and state law. If you received this communication in error, please do 
 not
 distribute any part of it or retain any copies, and delete the original 
 E-Mail.
 Please notify the sender of any error by E-Mail.
 
 Thank you for your cooperation.
 
 
 ___
 Histonet mailing list
 Histonet@lists.utsouthwestern.edu
 http://lists.utsouthwestern.edu/mailman/listinfo/histonet
  
___
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet


[Histonet] CAP Question, New Reagent Lot Confirmation of Acceptability

2014-03-26 Thread Laurie Colbert
The above checklist item, ANP.22760, states The performance of new lots of 
antibody and detection system reagents is compared with old lots before or 
concurrently with being placed into service.  Neither the question, the note 
below it, nor the evidence of compliance states that a pathologist has to 
perform the comparison.  What are other labs doing?  Are the histotechs signing 
off on new lots?

Laurie Colbert, HT (ASCP)
Histology Supervisor
PATH MD
8158 Beverly Blvd.
Los Angeles, CA  90048
(323) 648-3214 direct
(424) 245-7284 main lab

The information contained in this transmission may contain privileged and 
confidential information, including patient information protected by federal 
and state privacy laws. It is intended only for the use of the person(s) named 
above. If you are not the intended recipient, you are hereby notified that any 
review, dissemination, distribution, or duplication of this communication is 
strictly prohibited. If you are not the intended recipient, please contact the 
sender by reply email and destroy all copies of the original message.


___
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet


[Histonet] IHC on animals

2014-03-26 Thread Lester Raff MD
Hi:

 

Can IHC validated for humans be performed on animal tissues without any
protocol changes?

 

Thanks,

 

Lester J. Raff, MD MBA

UroPartners

Medical Director Of Laboratory

2225 Enterprise Dr. Suite 2511

Westchester, Il 60154

Tel: 708-486-0076

Fax: 708-492-0203

 

___
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet


[Histonet] Frozen sectioning whole rat eyes

2014-03-26 Thread William J. O'Connor III

Hello Histoland!
A colleague of mine is trying to section unfixed whole rat eyes in OCT.  She is 
getting a lot of tearing at the top of her section.  Lens and optic nerve on 
the horizontal plane.  Any suggestions, recommendations would be great!
Jackie

___
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet


Re: [Histonet] IHC on animals

2014-03-26 Thread Jan Shivers
Dr. Raff,

You will need to do trial runs to first determine if the antibody can
detect the specific epitope in animal tissues (epitopes aren't always
conserved between species), and then do your own optimization to determine
the best dilution and tissue pretreatment for that particular species.
 They can vary by species, and don't always coincide with the
recommendations on the antibody data sheet provided by the vendor.

-- 
Jan Shivers
Senior Scientist
IHC/Histology Section Head
Pathology Teaching Program
Veterinary Diagnostic Laboratory
University of Minnesota
1333 Gortner Ave.
St. Paul, MN  55108
612-624-7297
shive...@umn.edu



On Wed, Mar 26, 2014 at 3:03 PM, Lester Raff MD lr...@uropartners.comwrote:

 Hi:



 Can IHC validated for humans be performed on animal tissues without any
 protocol changes?



 Thanks,



 Lester J. Raff, MD MBA

 UroPartners

 Medical Director Of Laboratory

 2225 Enterprise Dr. Suite 2511

 Westchester, Il 60154

 Tel: 708-486-0076

 Fax: 708-492-0203



 ___
 Histonet mailing list
 Histonet@lists.utsouthwestern.edu
 http://lists.utsouthwestern.edu/mailman/listinfo/histonet

___
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet


[Histonet] RE: IHC on animals

2014-03-26 Thread Elizabeth Chlipala
Lester

I would not, first of all not all antibodies that work in human will cross 
react with a particular species of animal.  Another thing to consider is that 
most human based detection systems consist of dual link reagents, meaning that 
they work on both mouse and rabbit primaries these detection system are not 
ideal for working with animals and depending upon the species that you are 
working with may cause some problems in with background staining due to the 
secondary antibody or polymer binding to endogenous IgG in the samples.  You 
can initially pilot your protocol on a particular species to see what happens 
but I would not take the chance and run a bunch of slides thinking that the 
protocol that you have in place will work in the particular species of animal 
you need to stain.

Good Luck

Liz

Elizabeth A. Chlipala, BS, HTL(ASCP)QIHC
Premier Laboratory, LLC
PO Box 18592
Boulder, CO 80308
(303) 682-3949 office
(303) 682-9060 fax
(303) 881-0763 cell
l...@premierlab.com
www.premierlab.com

March 10, 2014 is Histotechnology Professionals Day

Ship to Address:

Premier Laboratory, LLC
1567 Skyway Drive, Unit E
Longmont, CO 80504


-Original Message-
From: histonet-boun...@lists.utsouthwestern.edu 
[mailto:histonet-boun...@lists.utsouthwestern.edu] On Behalf Of Lester Raff MD
Sent: Wednesday, March 26, 2014 2:03 PM
To: histonet@lists.utsouthwestern.edu
Subject: [Histonet] IHC on animals

Hi:

 

Can IHC validated for humans be performed on animal tissues without any 
protocol changes?

 

Thanks,

 

Lester J. Raff, MD MBA

UroPartners

Medical Director Of Laboratory

2225 Enterprise Dr. Suite 2511

Westchester, Il 60154

Tel: 708-486-0076

Fax: 708-492-0203

 

___
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet

___
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet


[Histonet] Body Release and Cleanin in Morgue

2014-03-26 Thread Scott, Allison D
Hello to all in histo-land.  Who takes care of releasing the body to the 
funeral home and who does the cleaning of the seals and the molds on the 
drawers for the body storage?  Is lab some how involved in this process?


Allison Scott HT(ASCP)
Supervisor, Histology Lab
LBJ Hospital
Harris Health System
Office: 713-566-2148
Lab: 713-566-5287


CONFIDENTIALITY NOTICE:
If you have received this e-mail in error, please immediately notify the
sender by return e-mail and delete this e-mail and any attachments from 
your computer system.

To the extent the information in this e-mail and any attachments contain 
protected health information as defined by the Health Insurance Portability 
and Accountability Act of 1996 (HIPAA), PL 104-191; 45 CFR Parts 160 and 
164; or Chapter 181, Texas Health and Safety Code, it is confidential and/or 
privileged.  This e-mail may also be confidential and/or privileged under 
Texas law.  The e-mail is for the use of only the individual or entity named 
above.  If you are not the intended recipient, or any authorized 
representative of the intended recipient, you are hereby notified that any 
review, dissemination or copying of this e-mail and its attachments is 
strictly prohibited.

___
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet


[Histonet] RE: IHC on animals

2014-03-26 Thread pruegg
Lester,

Probably not in most cases but it depends upon what the antibody is, whether
as a an antihuman ab it also cross reacts to the species you are interested
in and what detection reagents you are using.
For instance if you have determined a rabbit anti human antibody also cross
reacts in mouse tissue, you could use a detection such as for the Leica Bond
by leaving out the link (they call it the post primary but it is rabbit anti
mouse IgG to link mouse antibodies to the goat anti rabbit labeled polymer
second step), since your ab is rabbit it would link directly to the anti rab
labeled polymer and the anti mouse link which would bind non specifically to
the mouse endogenous Ig can be avoided. 
You would have to do a lot of research to first determine if the anti human
rabbit antibody you want to use (it should not be made in a mouse) cross
reacts to mouse tissue.  The species you are wanting to label is also very
important, this system would only work for anti human rab abs that also
react in mouse, rat or any other species except rabbit and goat because
those are the species the detection is made in or against.
We have research versions of the Leica Bond instruments which allows us to
manipulate the instrument and detection for these purposes including
replacing the rab anti ms link with another link, I am not sure if the pure
clinical versions of the Bond allow this.
Cheers,
Patsy

Patsy Ruegg, HT(ASCP)QIHC
Ruegg IHC Consulting
40864 E. Arkansas Ave
Bennett, CO 80102
H 303-644-4538
C 720-281-5406
prueg...@hotmail.com 

-Original Message-
From: histonet-boun...@lists.utsouthwestern.edu
[mailto:histonet-boun...@lists.utsouthwestern.edu] On Behalf Of Elizabeth
Chlipala
Sent: Wednesday, March 26, 2014 2:20 PM
To: Lester Raff MD; histonet@lists.utsouthwestern.edu
Subject: [Histonet] RE: IHC on animals

Lester

I would not, first of all not all antibodies that work in human will cross
react with a particular species of animal.  Another thing to consider is
that most human based detection systems consist of dual link reagents,
meaning that they work on both mouse and rabbit primaries these detection
system are not ideal for working with animals and depending upon the species
that you are working with may cause some problems in with background
staining due to the secondary antibody or polymer binding to endogenous IgG
in the samples.  You can initially pilot your protocol on a particular
species to see what happens but I would not take the chance and run a bunch
of slides thinking that the protocol that you have in place will work in the
particular species of animal you need to stain.

Good Luck

Liz

Elizabeth A. Chlipala, BS, HTL(ASCP)QIHC Premier Laboratory, LLC PO Box
18592 Boulder, CO 80308
(303) 682-3949 office
(303) 682-9060 fax
(303) 881-0763 cell
l...@premierlab.com
www.premierlab.com

March 10, 2014 is Histotechnology Professionals Day

Ship to Address:

Premier Laboratory, LLC
1567 Skyway Drive, Unit E
Longmont, CO 80504


-Original Message-
From: histonet-boun...@lists.utsouthwestern.edu
[mailto:histonet-boun...@lists.utsouthwestern.edu] On Behalf Of Lester Raff
MD
Sent: Wednesday, March 26, 2014 2:03 PM
To: histonet@lists.utsouthwestern.edu
Subject: [Histonet] IHC on animals

Hi:

 

Can IHC validated for humans be performed on animal tissues without any
protocol changes?

 

Thanks,

 

Lester J. Raff, MD MBA

UroPartners

Medical Director Of Laboratory

2225 Enterprise Dr. Suite 2511

Westchester, Il 60154

Tel: 708-486-0076

Fax: 708-492-0203

 

___
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet

___
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet



___
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet